 |
 |

Clinically Significant Pancreatic Fistulas
Tetsuji Fujita, MD
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
Despite its suboptimal retrospective design, the article by Veillette and colleagues1 in the May issue of the Archives illustrating the clinical importance and updated management of pancreatic fistulas after pancreaticoduodenectomy provides critical information for practicing surgeons. The patient data were prospectively collected in a high-volume hospital, where about 106 pancreaticoduodenectomies are performed annually. In their study, a pancreatic fistula was identified when there was continuous external drainage for 7 days or an intraabdominal collection of amylase-rich fluid. The authors divided pancreatic fistulas into low-impact fistulas, which could usually be treated on an outpatient basis with favorable consequences (n = 26), and high-impact fistulas, which resulted in major morbidity and/or mortality despite rigorous intervention (n = 46). High-impact fistulas were divided into overt (n = 33) and occult (n = 13) fistulas. Occult fistulas were defined as those that were not manifest in the first postoperative week but subsequently resulted in fistula-related major morbidity. High-impact pancreatic . . . [Full Text of this Article] AUTHOR INFORMATION
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
RELATED ARTICLE
Implications and Management of Pancreatic Fistulas Following Pancreaticoduodenectomy: The Massachusetts General Hospital Experience
Gregory Veillette, Ismael Dominguez, Cristina Ferrone, Sarah P. Thayer, Deborah McGrath, Andrew L. Warshaw, and Carlos Fernández-del Castillo
Arch Surg. 2008;143(5):476-481.
ABSTRACT
| FULL TEXT
RELATED LETTER
Clinically Significant Pancreatic Fistulas—Reply
Gregory Veillette and Carlos Fernández-del Castillo
Arch Surg. 2008;143(11):1132-1133.
EXTRACT
| FULL TEXT
|